Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kakolyris

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Anticancer Research|July 23, 1998
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomasK Stefanaki, D Rontogiannis, C Vamvouka, et al.
American Journal of Clinical Oncology|June 17, 2000
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five casesC Kouroussis, G Samonis, N Androulakis, et al.
Anticancer Research|March 23, 2002
Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39S Kakolyris, A Giatromanolaki, M Koukourakis, et al.
Clinical and Experimental Pathology|December 22, 1999
Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disordersP Kanavaros, K Stefanaki, D Rontogianni, et al.
American Journal of Clinical Oncology|February 2, 2002
Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II studyL Vamvakas, S Kakolyris, C Kouroussis, et al.
Oncology|August 4, 2011
Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancerK Amarantidis, N Xenidis, L Chelis, et al.
American Journal of Clinical Oncology|July 28, 2001
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumorsC Kouroussis, S Kakolyris, D Mavroudis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic CancerG P Stathopoulos, D Mavroudis, N Tsavaris, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
A dose escalation study of weekly docetaxel in patients with advanced solid tumorsC Kouroussis, S Agelaki, D Mavroudis, et al.
Oncology|May 8, 2001
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancerS Kakolyris, J Souglakos, C Kouroussis, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Anticancer Research|July 23, 1998
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomasK Stefanaki, D Rontogiannis, C Vamvouka, et al.
American Journal of Clinical Oncology|June 17, 2000
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five casesC Kouroussis, G Samonis, N Androulakis, et al.
Anticancer Research|March 23, 2002
Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39S Kakolyris, A Giatromanolaki, M Koukourakis, et al.
Clinical and Experimental Pathology|December 22, 1999
Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disordersP Kanavaros, K Stefanaki, D Rontogianni, et al.
American Journal of Clinical Oncology|February 2, 2002
Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II studyL Vamvakas, S Kakolyris, C Kouroussis, et al.
Oncology|August 4, 2011
Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancerK Amarantidis, N Xenidis, L Chelis, et al.
American Journal of Clinical Oncology|July 28, 2001
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumorsC Kouroussis, S Kakolyris, D Mavroudis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic CancerG P Stathopoulos, D Mavroudis, N Tsavaris, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
A dose escalation study of weekly docetaxel in patients with advanced solid tumorsC Kouroussis, S Agelaki, D Mavroudis, et al.
Oncology|May 8, 2001
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancerS Kakolyris, J Souglakos, C Kouroussis, et al.
Pageof 13